We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Booster Effect of Oral Poliovaccine Trials in Persons Previously Immunized With Inactivated Vaccine

Robert H. McCollough, MD; W. Paul Glezen, MD; George A. Lamb, MD; Tom D. Y. Chin, MD
Am J Dis Child. 1969;117(2):161-168. doi:10.1001/archpedi.1969.02100030163008.
Text Size: A A A
Published online


EITHER formaldehyde-solution-inactivated poliovaccine (IPV) or live-attenuated poliovaccine (OPV) may be used for poliomyelitis immunization. In the United States OPV is now administered more frequently than IPV.1 Moreover, many persons previously vaccinated with IPV have now received a complete series of monovalent OPV as secondary immunization. The number of persons under 20 years of age thus vaccinated was estimated from Bureau of Census data to number 30 million in 1965.1

Several studies have confirmed that single doses of monovalent OPV do provide adequate booster responses in IPV-vaccinated persons.2-5 Similarly, clinical trials with the newer trivalent vaccines have included assessment of their value as booster agents. A single dose of balanced trivalent OPV has been successfully used to fill immunologic gaps in populations possessing a high degree of natural immunity.6-8 Two doses of high titer vaccine have yielded a good response in preschool IPV-vaccinated children.9 However, small


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.